Disclaimer: We aren’t paid by companies to write analysis on Trading For Millions ― it’s 100% independent. We also aren’t licensed to provide financial advice on the blog. Trading For Millions analyses companies we own for fun and tracks our performance live in real time. Please perform your own research on each company profiled on the blog.
Impression Healthcare Limited (ASX:IHL) has gone from zero to hero.
Since our founding analysis on 7 March, the share price has doubled and the options have quadrupled. Our portfolio value has more than doubled (see position update below), with many of our readers sitting on significant gains. If you are new to our website, we’ve written about the company’s business at length, here (7 March) and here (25 March). That’s when the share price was trading at 2 cents, compared to 3.6 cents.
Now, prior to sharing our latest thoughts on the company (the market still hasn’t caught on to the full story yet), we want to give you a position update and tell you what’s happening with Trading For Millions these days.
Position update on Impression Healthcare
Here’s the previous position update from a smaller account on 2 May 2019:
One analyst originally invested close to $50,000 in the company. Remember, while we hold significantly more shares in other accounts, the blog’s goal is to turn a small amount of money into a million dollars. The smaller number is therefore held in a nominee account for privacy purposes and disclosing what we own makes us different from everyone else on the internet.
Here’s the latest position update from the smaller account on 22 June 2019:
We haven’t sold any shares yet and our small account has grown to $103,000 at current prices. Indeed, while we’re still relatively unknown, Trading For Millions is in business.
The latest news from Trading For Millions
Remember, we started the website because we got sick of newsletter and trading charlatans. We haven’t come across a single newsletter or trading guru that’s made consistent profits for readers. We also haven’t found a paid research website that’s helped anyone other than company management. That’s why we started the blog, putting our hard-earned money on the line.
We don’t write up junk on Trading For Millions.
If we make money, you make money (assuming you buy what we buy).
Other websites pump out content because they get paid by companies or are trying to sell newsletters. There’s no need to pump out content here because we aren’t paid by companies, nor are we trying to sell anything on the blog. That’s why we don’t write all the time. We make money from the markets ― not this website ― as shown by IHL.
Nonetheless, starting with Impression Healthcare, we’re passionate about building an excellent track record at Trading For Millions. We want to be known for picking great stocks and making bucket loads of money. If we turn a small sum of money into a substantial amount (IHL has already doubled), we will get an accounting firm to audit our accounts to prove legitimacy.
In the meantime, while investing our capital into companies on the Live Trading Blog, we are writing a trading course for FREE. If you go to the education part of the website, you will find three parts of the course ― Trader University ― available today. It focuses on mastering the basics of trading and having the right framework in place to succeed.
Trader University’s course content is discussed here.
That said, while we planned to get our full course out by mid-year, we have been held up with trading and travelling. Sorry for the delay. The good news is that we should finish the course by the end of July, with two more chapters left. We’re currently working on the content and talking with quality brokers, with the intention of getting you discounted commission rates.
In conjunction with the course, we plan to start a small portfolio challenge on the blog. The goal is to grow a small amount of capital into a million dollars; hence the name Trading For Millions. We outlined how you can make this happen in Trader University. So, unlike trading charlatans, we will put our money where our mouth is and show you how to do it properly.
This might sound like a joke.
But, as evidenced with IHL, we believe we have the skills to trade for millions. Again, if we make a substantial amount of money, we will get everything audited by an accounting firm to prove legitimacy.
Trading For Millions also just launched a ‘Hot Stock News’ blog. This is where we cover companies we don’t own, but look interesting. We will analyse at least one company per day. The goal is to build our watch list and teach you a thing or two about analysis. We will return to this schedule after completing our free trading course ― Trading University.
Note: You won’t receive emails from the ‘Hot Stock News’ blog. You will need to go to the website to see which company is covered each day. We will only send emails on content written on the Live Trading Blog, with the intention of keeping your inbox clean. That said, when we write something on the Hot Stock News blog, we will post it to our Facebook and Twitter pages.
Finishing the trading course is our priority, mind you.
Trading For Millions will also add another deep value investment opportunity to the blog. When the timing is right, we will take partial gains on Impression Healthcare (we will let you know when this happens) and analyse another play on the blog. But we’re unsure whether to sell any shares soon, with the potential to see 10 cents within six to 12 months (see below). Why sell an undervalued winner, which could go sharply higher within six months?
There’s lots to think about…
For this reason, with plenty left on the table for IHL, let’s jump to the standard disclaimer before talking about our latest thoughts on the company.
Standard disclaimer: Do your own research
This disclaimer section will never change. But it’s extremely important as we don’t have a financial licence and write this blog for enjoyment. We don’t get paid by companies to write research ― everything is 100% independent on Trading For Millions. The incentive is to make good money from the stocks on the Live Trading Blog and help you with your own investing.
If you invest alongside us, you do so at your own risk.
Remember, we own shares across multiple accounts in each company on the Live Trading Blog. The position update is a nominal amount for track record purposes. For this reason, as we are professional traders, we could be selling every rally with our accounts ― even the account disclosed on Trading For Millions.
Buy at your own risk.
With this in mind, if we grow a reputation for selecting bad stocks, we won’t have any readers!
Trading For Millions will only grow its readership by buying good companies with potential, where you can see the story play out in real time. The goal is to hit multiple homeruns in order to grow. We believe Impression Healthcare will be the start of a tremendous track record, as we have said for many months.
Just be aware that we could be selling when you’re buying…
Aside from the possible conflicted intentions stated above, we’re not in the business of providing formal stock recommendations or financial advice on Trading For Millions. If you want to know when to buy or sell a company, you’ve come to the wrong place. Learn to trade by reading our free course ― Trader University ― and figuring out what not to do!
Trading For Millions is a hobby blog.
That might change one day.
But not anytime soon.
You should perform your own research on every company profiled on Trading For Millions. Our analysis is skewed to the positive side, as we hold shares in each company on our Live Trading Blog. Trading For Millions will disclose whether we sell any shares in a company. But, again, we will only grow this blog by picking good quality companies and tracking them in real time.
To read the rest of the article, you need to sign up to our blog (for FREE). You can do this below. Becoming a member will give you access to our FREE trading course, Trader University. You will also receive email updates from our Live Trading Blog, documenting our deep value plays (currently IHL) and the future small portfolio challenge.
Let’s get stuck into the company’s latest story…